Drugs.com - Pharma Industry News

Nirsevimab Effective for Reducing Burden of RSV in Infants

THURSDAY, May 8, 2025 -- Nirsevimab is effective for reducing the burden of respiratory syncytial virus (RSV) in infants in real-world settings, according to a study published online May 1 in The Lancet Child & Adolescent Health.Dewan Md...

May 8, 2025 - 19:01
 0
Nirsevimab Effective for Reducing Burden of RSV in Infants
THURSDAY, May 8, 2025 -- Nirsevimab is effective for reducing the burden of respiratory syncytial virus (RSV) in infants in real-world settings, according to a study published online May 1 in The Lancet Child & Adolescent Health.Dewan Md...
Read More

Tags:

Previous Article

Mindfulness Training Improved Positive Emotion Regulation in OUD

Next Article

Study IDs Trends in 2015 to 2023 Mortality for Chronic Liver Disease

Related Posts

Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists

Many Medicaid Enrollees Have Restricted Access to SGLT2...

Apr 30, 2025  0

Urticaria Reported in Trial of Investigational HIV mRNA Vaccines

Urticaria Reported in Trial of Investigational HIV mRNA...

May 5, 2025  0

Ultraprocessed Food Consumption Linked to Nonmotor Prodromal Parkinson Disease

Ultraprocessed Food Consumption Linked to Nonmotor Prod...

May 8, 2025  0